CIO Life Sciences Summit Agenda
December 9-12, 2012

Networking Opportunities & Session Breaks

Executive Exchange

CIO Keynote Presentation

CIO Focus Group

A visionary speaker addresses the entire summit audience on a topic determined by the CIO Content Committee.

Led by a vendor, these sessions allow executives to discuss business drivers within a particular area of technology. Presentations are 15-20 minutes followed by 10-15 minutes of Q&A.

CIO Executive Visions

Analyst Q&A Session

A panel of IT executives has an in-depth discussion on a critical IT business topic. Audience members have an opportunity to pose questions to the panelists and moderator.

A high-impact, open-forum session covering the latest technology research and led by a member of our analyst partner community.

CIO Thought Leadership

Vendor Showcase

Led by a member of the vendor community, these sessions will provide an overview of cutting edge technology topics and pressing business concerns.

Presented by a member of the vendor community, these sessions are divided into three 10-minute long elevator pitches on the newest technology solutions and services.

CIO Think Tank

CIO Case Study

Focusing on a specific topic or initiative, these interactive, open-forum style sessions allow the attending 15-20 executives to discuss best practices and have lively debates.

Learn about recent technology implementations from the IT executives who drove the projects at their organizations. Presentations are followed by Q&A sessions.

CIO/CTO Roundtable

CIO Open Forum Luncheon

An interactive, focused session led by either an analyst, industry expert or member of the vendor community.

Led by a moderator, these sessions allow attendees to have informal discussions on pre-determined technology topics.

Day 1: Sunday, December 9th - CIO Life Sciences Summit

Registration & Greeting to the CIO Life Sciences Summit

Executive CIO Think Tank

*An exclusive invitation only, pre-summit think tank for CIOs

6:00pm - 7:00pm

Welcome Reception

7:00pm - 10:00pm

Welcome Address & Gala Dinner

Day 2: Monday, December 10th - CIO Life Sciences Summit

7:00am - 8:00am

Networking Breakfast

8:10am - 8:50am

Opening CIO Keynote Presentation

The End of the Information Silos

As organizations grow and reach a certain size, they frequently share a common characteristic. It is the affliction of the right hand not knowing what the left hand is doing. Incapable of reciprocal operation with other management systems, an information silo is a system steering towards its doom. The symptoms of the silo effect are easy to recognize: lack of cooperation, internal competition and breakdown in communication. What can we do to eliminate the silos? Knocking down the barriers can be an important contributor to value creation - and it will make way for sharing services, skills and systems across units, all the while encouraging best practices.

9:00am - 9:30am

Executive Exchange

CIO Thought Leadership

Aligning Business & IT Trends

In order to be successful in an ever-evolving market, life sciences companies must be keenly aware of the latest IT and business trends impacting the industry; and quickly embrace and implement the IT solutions that will address the challenges of the business changes. Recent studies show that some of the issues of greatest concern to bio-pharmaceutical executives are the changing commercial business model, regulatory compliance, pipeline growth, fragmented business processes and access to accurate data. This presentation will discuss best practices for addressing these and other issues with innovative IT solutions that promote speed, flexibility, agility and collaboration. Cloud computing, mobility, analytics, digital profiling and other IT tools will be discussed.

9:35am - 10:05am

Executive Exchange

CIO Think Tank

Building Internal Infrastructure to Drive Success in Digital Marketing

Describing the role IT can play in supporting, governing and building the enterprise capability required to drive digital channel marketing success within a life sciences organization. This session walks through one successful approach for enabling effective partnerships between Brand teams, Agency and various service providers to deliver quality digital solutions.

10:10am - 10:40am

Executive Exchange

CIO Thought Leadership

Mobility: Enhancing Business Value in Pharma

Enterprises are convinced that they must embrace mobility and unlock its potential benefits. However, this area is still evolving and there are few best practices and standards. New tools, technologies and approaches are emerging frequently to address the enterprise needs. We will discuss the challenges faced by CIOs as they integrate mobile devices into the enterprise and also how they are pushing forward in spite of the nebulous environment. We will briefly cover the technology landscape and discuss how the pharmaceutical sector is committing to mobility programs that drive business value. We will close with a discussion of the high-priority enterprise mobile applications for pharmaceutical companies.

10:40am - 11:05am

Networking Break

11:10am - 11:40am

Executive Exchange

CIO Thought Leadership

A Scalable Unified Architecture for NGS and Research Computing Data Management

In this presentation we will discuss how we can deliver a unified data storage and management solution that can accelerate data ingestion from the instruments, increase the performance of an in-place sequencing pipeline - and have the ability to intelligently archive and share research data in a geographically distributed manner. We will also discuss how the use of high performance, scalable storage building blocks can deliver an array of flexible, highly scalable and easy to manage storage solutions that are helping research groups around the world accelerate their time to discover,y with innovative storage and archival solutions that have lowered the cost and simplified the processing,retention and management of the data life cycle.

11:45am - 12:15pm

Executive Exchange

CIO Think Tank

Can We Stay Out of Our Own Way? Technology and Governance as Key Enablers of External Collaboration

Big Pharma is famous for erecting security barriers second to none, but as the model for R&D shifts to one of extensive external partnership and collaboration, those same protective walls become impediments to change, advancing science, and, ostensibly, competitive advantage. Couple this with inconsistent data standards and the emergence of massive data sets, and it's a wonder we can collaborate at all!

In this open forum session, we will seek comments on a framework for external collaboration that leverages IT's rich history of governance and technology introduction, hopefully without also placing itself in the way of progress.

CIO Thought Leadership>

7 Lessons for Effective Mobile Strategies

Given changes in the market for pharmaceuticals, the effective use of social media, collaboration tools, and mobility will be key for life science and pharmaceutical companies seeking to grow and innovate effectively with the market. This session will focus on the CIO agenda for Mobile, and how to stay on top of demand with a proactive Mobile strategy. We will share key lessons learned on how to promote innovation while maintaining control over digital initiatives.

12:55pm - 1:55pm

CIO Networking Luncheon

2:00pm - 2:30pm

Executive Exchange

CIO Thought Leadership

R&D: The Final IT Frontier

Business process technology for R&D in life science organizations has lagged behind the commercial side in delivering transformational change, measurable efficiencies and stakeholder transparency. Technology for clinical development addresses one of the costliest and most critical life science activities, but must account for specialized functional silos, regulatory and QA skepticism, and multiple users. The result today is often a landscape of non-integrated, point solutions, often with significant implementation and support needs. With current industry pressures, the time is right to look to leverage lessons learned from the successful deployment of enterprise systems in commercial activities.

This presentation will address the use of technology to reach a future state of clinical development, where enterprise-like solutions, built on integrated, SaaS platforms, can support process change, business intelligence and real-time operational management.

2:35pm - 3:05pm

Executive Exchange

CIO Think Tank

Large Capacity Scale Out: The First 10 Petabytes are the Hardest

The age of inexpensive genomic sequencing, imaging, and other large data generation is upon us. With the new research sciences are an exponential demand for more storage, compute and bandwidth. Traditional "best practices" get challenged as IT becomes either the new collaborative, innovative partner with the researchers, or becomes the slow, expensive roadblock to continued growth and competitiveness. In this session, we'll discuss various challenges and solutions around developing and managing multi-petabyte scale IT in Life Sciences Research.

3:10pm- 3:40pm

Executive Exchange

CIO/CTO Roundtable

Secure Management of Mobile Assets, Content and Applications

Mobile security has evolved well past device restrictions and passcode policies. Enterprises must adopt and implement more advanced security techniques to protect sensitive content, mobile applications and access to internal enterprise and cloud services. The session will cover:

3:45pm - 4:15pm

Executive Exchange

CIO Thought Leadership

Time and its Effect on the Value of Information

Time and information are business assets. Applied together, they can have a compounding effect on business value. In this session we will explore the value of time in applying information to opportunities and challenges. Learn how time has a compounding effect on the value of information, and hear examples of how some companies have benefited from that effect. We will introduce the concept to frame a discussion around strategies and technologies you can use in your organization to achieve breakthrough results.

Discover how you can reduce the time between business event and action and use that time to change your business.

4:25pm - 4:55pm

Executive Exchange

CIO Think Tank

Social Media and Pharmaceutical Sales

Trying to utilize new social networks to boost sales and marketing efforts? In this thought-provoking open-forum session, we will discuss social media for Life Sciences organizations in terms of opportunities, challenges, risks and positioning. Will Social Media be used by pharmaceutical companies solely as "business support tools for increased brand recognition, low-cost promotions, and increased selling opportunities" or can it be used to improve patient outcomes, as well?

5:00pm - 5:30pm

Executive Exchange

CIO/CTO Roundtable

Compliance in the Cloud: On Demand for the Life Sciences Industry

5:30pm - 7:00pm

Reception

7:00pm - 9:30pm

Gala Dinner

9:30pm - 10:30pm

After Dinner Networking

Day 3: Tuesday, December 11th - CIO Life Sciences Summit

7:30am - 8:15am

Networking Breakfast

8:20am - 9:20am

CIO Executive Visions

Catching the Next Life Sciences Wave

The American Life Sciences industry are operating in an environment of unprecedented and unrelenting change. Companies are faced with harnessing the promise of great discoveries amid the challenges of increasing regulations, pricing pressures and heightened market and public expectations. Organizations must act quickly, responsibly and effectively to grow and pick market shares. What are the strategies Life Sciences organizations must adopt to achieve success over the next decade? This panel will discuss some of the challenges the CIOs will have to face, and how they can utilize innovative IT solutions to overcome them:

9:30am - 10:00am

Executive Exchange

CIO Think Tank

Novel Architectures, Methods, Processes and Collaborations to Speed Discovery

The Big Data sets created by the Healthcare System (academia, biopharma, government, healthcare delivery and payors) are creating opportunities and challenges to deliver more effective care and solutions. Consolidated data sets from multiple sources, providing a single version of the truth, need to implemented and maintained across disease spectrums - from the bench to the bedside. Over the past several years, new architectures (Cloud, hybrid FPGA and GPU), originally developed for the commercial markets, have gained an important foothold in research and development. Used in combination with traditional High Performance Computing (HPC) architectures they can significantly shorten discovery cycles. Efficient conversion of discoveries into effective medicines will require seamless integration of not only discovery and applied science, but also the exploratory and goal-oriented cultures in academia and industry. Effective Big Data research collaborations across academia, government, industry and healthcare delivery will create a cost effective Healthcare System.

10:05am - 10:35am

Executive Exchange

CIO/CTO Roundtable

The Nine Dimensions of Commercial Excellence

Life Science companies have seen a set of massive paradigm shifts in recent years. These include consumerism and patient centricity through large increases in the cost of R&D, through pricing fluctuations and addressing revenue management. Therefore the need for better commercial operations.

To achieve this, there is a move towards "Commercial Excellence." During this session, we will share with you some perspectives on ways organizations can take positive steps internally with technology accelerators and at the same time keep watch of external influences to monitor and develop proactive strategies.

This interactive session will enable us to share our views with you, on the nine dimensions of Commercial Excellence and the technology accelerators that align with these dimensions. Participants are encouraged to share their experiences with CRM and Key Account Management, Enhancing the capabilities of the Sales Force, Multichannel Marketing, deploying and overseeing Social Media and other alterative channels.

10:40am - 11:10am

Executive Exchange

CIO Think Tank

Evolution of Drug Discovery: Role of Knowledge Management for Novel Disease Indications

Typically drugs have been repurposed following serendipitous observations. Now, however, there are a number of computational methods that can evaluate and suggest new indications for a drug. We will discuss some of these methods that are based on genetics, gene expression signatures, text-mining literature, and pathways.

11:10am - 11:30am

Networking Break

11:35am - 12:05pm

Executive Exchange

CIO Think Tank

Where is the ROI for Targeted Therapies and Personalized Medicine?

This open-forum session will discuss how personalized medicine - as defined by the concept of using genetic data and significant IT resources to provide specialized medicine for individual patients - is slowly moving into the Life Science and Healthcare mainstream, though only a few practical applications exist to date. When it does become more practical, it may be a financial blessing. New reports suggest that personalized medicine could provide significant ROI for all of the key stakeholders.

12:10pm - 12:40pm

Executive Exchange

CIO Think Tank

Clinical Research and Improving Quality of Care - The Role of Data Warehousing

Clinical research and clinical care both seek to improve health outcomes. Traditional clinical research has focused on prospective studies to identify factors for improving care and prevention. Process improvement and quality initiatives seek to improve the delivery of care and optimize the patient experience for better individual outcomes. Both types of data can be effectively combined and mined using data warehousing. However, overseeing the appropriate use and interpretation of these data can be difficult. We will present one possible approach for handling clinical research data, identifying participants in the medical record, and one strategy for appropriately coupling high dimensional data such as genomic data to clinical outcomes.

CIO Networking Luncheon

1:50pm - 2:20pm

Executive Exchange

CIO Think Tank

On the Interactions Between CROs and Big Pharma/Biotech

2:25pm - 3:05pm

Closing CIO Keynote Presentation
with Concluding Remarks & Takeaways

A Vision of the Future

The scale and breadth of the challenges facing the Life Sciences industry in the coming years are truly breathtaking. A changing health market, new regulatory pressures, even-higher hurdles for innovation and declining R&D productivity are all taking their toll on traditional business models and biomedical research.

Traditionally, pharmaceutical companies were bound by their organizational structure. IT services was aligned to the individual business units (i.e. R&D, Operations, Sales and Marketing), and provisioned directly to them. Today, the industry is responding in a number of ways, including moves towards new organization models in R&D and Commercial, a drive to lean operations and an increase in M&A and licensing activity. The Life Sciences industry must take a hard look at the way they perform IT operations and decide if these methods and solutions are sufficiently effective.

3:05pm - 7:00pm

Relaxation & Recreation Time

7:00pm - 9:30pm

Farewell Dinner & Networking